Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 5 , ISSUE 1 ( January-June, 2015 ) > List of Articles

MINI REVIEW

Epidemiology of Viral Hepatitis and Liver Diseases in Bangladesh

Citation Information : Epidemiology of Viral Hepatitis and Liver Diseases in Bangladesh. Euroasian J Hepatogastroenterol 2015; 5 (1):26-29.

DOI: 10.5005/jp-journals-10018-1124

License: CC BY-NC 4.0

Published Online: 01-01-2015


Abstract

Bangladesh is a South Asian country with a homogeneous population. However, some difference has been demonstrated in the distribution of liver disease in different parts of the country. Hepatitis E remains the principal cause of acute hepatitis in Bangladesh, while chronic liver disease in Bangladesh, including hepatocelullar carcinoma, is predominantly due to hepatitis B virus. Hepatitis B has been extensively studied and characterized in Bangladesh, and some major clinical trials with HBV-related antigens have also been conducted.


PDF Share
  1. Rahman S, Mahtab MA, Foster G, Khan M, Karim MF, Solaiman S, Afroz S. Epidemiology of hepatitis B virus in Bangladeshi General Population. Hepato Bil Pancreat Dis Int 2008;7(6):595-600
  2. Clinical use of liver biopsy for the diagnosis and management of inactive and asymptomatic hepatitis B virus carriers in Bangladesh. J Med Virol 2010;82(8):1350-1354
  3. Biochemical, virological, immunological and histopathological features of 702 incidentally detected chronic hepatitis B virus carriers in Bangladesh. Digestion 2012;86(1):1-5
  4. Genotypes of hepatitis B virus among chronically infected patients in a tertiary care hospital in Bangladesh. Indian J of Gastroenterol 2006;25(4):219-221
  5. Pre-core/core Promoter mutant hepatitis B virus produces more severe histologic liver disease than wild type hepatitis B virus. Hungarian Med J 2007;1(1):41-46
  6. Viral load speaks little about toll on liver. Hepato Bil Pancreat Dis Int 2007;6(4):223-226
  7. Assessment of clinical utility of low and high normal alanine aminotransferase values in patients with chronic hepatitis B virus Infection at Bangladesh. Digestion 2010;83(1-2):60-64
  8. Economic burden of chronic hepatitis B virus infection in Bangladesh. Hepatol Int 2012;6(1)(Suppl):129
  9. Combination therapy with antiviral drugs and hepatitis B vaccine in incidentally-detected Epidemiology of Viral Hepatitis and Liver Diseases in Bangladesh Euroasian Journal of Hepato-Gastroenterology, January-June 2015;5(1):26-29 29 EJOHG and asymptomatic chronic hepatitis virus B carriers at Bangladesh. Viral Immunol 2010;23(3):335-338
  10. Combination therapy of lamivudine and interferon alpha in pediatric patients with chronic hepatitis B at Bangladesh: a safe and effective therapeutic approach for pediatric CHB patients of developing countries. Int J Immunopathol Pharmacol 2010;23(2):659-664
  11. Response to combination therapy with ‘shorter duration’ and ‘half dose’ pegylated interferon and entecavir in chronic hepatitis B in Bangladesh. J Hepatol 2012;2(56)(Suppl):65
  12. Therapeutic potential of a novel therapeutic vaccine containing both hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) administered through mucosal and parental route in patients with chronic hepatitis B. Hepatology 2010;52(Suppl 4):538-539
  13. Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B. Hepatol Int 2013;7(4):981-989
  14. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan. Gastroenterol Jpn 1993;28(Suppl 5):28-31
  15. Seroepidemiology of hepatitis viruses of chronic liver diseases in Bangladesh: high prevalence of HCV among blood donors and healthy persons. Hepatol Res 1997;7(2):113-120
  16. Prevalence and risk factors of asymptomatic HCV infection in Bangladesh. J Clin Experiment Hepatol 2011;1(1):13-16
  17. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. MC Infect Dis 2010;10(1):208
  18. Seroprevalence of Hepatitis B, Hepatitis C, HIV Infections in blood donors of Khulna, Bangladesh. Mymensingh Med J 2010;19(4):515-519
  19. Indication of determination of antibodies against hepatitis C and A viruses in the protocol for the care of young immigrants. Gac Sanit 2010;24(4):288-292
  20. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat 2010;17(5):327-335
  21. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Popul Nutr 2000;18(3):145-150
  22. Prevalence of HBV and HCV among the multi-transfused beta thalassemic major patients in a day care centre of blood transfusion department of Mymensingh Medical College Hospital. Mymensingh Med J 2014;23(2):235-241
  23. HCV in Pakistani: a systematic review of prevalence genotypes and risk factors. World J Gastroenterol 2009;15(45):5647-5653
  24. Role of potash alum in hepatitis C virus transmission at barber’s shop. Virol J 2011 May 9;8:211
  25. Genotypes of HCV in Bangladesh: Experience from a tertiary centre. Hungarian Med J 2008;2(4):577-581
  26. Genotypes of HCV in Bangladesh: experience from a tertiary centre. J Gastroenterol Hepatol 2008;23(Suppl):27-28
  27. Peginterferon α-2a and rivabirin in the treatment of chronic Hepatitis C. Mymensingh Med J 2014 Apr;23(2):335-340
  28. Sustained virological response after treatment in patients with chronic hepatitis C infection—a 5-year follow-up. Bangladesh Med Res Counc Bull 2013;39(1):11-13
  29. Epidemiological and molecular analyses of a non-seasonal outbreak of acute icteric hepatitis E in Bangladesh. J Med Virol 2013;85(8):1369-1376
  30. HEV infection as an etiologic factor for acute hepatitis: experience from a tertiary hospital in bangladesh. J Health Popul Nutri 2009; 27(1):14-19
  31. Hepatitis E virus is the leading cause of acute-on-chronic liver disease: Experience from a tertiary centre in Bangladesh. Hepat Bil Pancreat Dis Int 2009;8(1):50-52
  32. Distribution of liver disease in Bangladesh: a cross country study. Euroasian J Hepato-Gastroenterol 2014;4(1):25-30
  33. Hepatitis B virus related hepatocellular carcinoma is the predominant cause of liver cancer in Bangladesh. J Acute Dis 2013;1(1):35-37
  34. Chronic liver disease is one of the leading causes of death in Bangladesh: experience by death audit from a tertiary hospital. Euroasian J Hepato-Gastroenterol 2014; 4(1):17-20.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.